drugset / Trial / NCT06962462

Daily Tadalafil in Diabetic ED Patients

NCT06962462

Not yet recruiting 60 enrolled South Valley University
RandomizedParallel-groupDouble-blindTreatment

Summary

This study evaluates the effect of 5 mg daily tadalafil therapy on serum levels of Endothelin-1 and E-selectin in diabetic male patients with erectile dysfunction. Outcomes will be compared pre- and post-treatment versus healthy controls.

Timeline

Start
2025-05-05
Primary completion
2025-08-05
Completion
2025-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Tadalafil Small molecule 5 mg Oral